ResearchMoz

Global Industrial Silica Sand Market 2012 - 2016

Technavio
Published Date » 2013-04-12
No. Of Pages » 40
TechNavio's analysts forecast the Global Industrial Silica Sand market to grow at a CAGR of 4.50 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of industrial silica sand for hydraulic fracturing. The Global Industrial Silica Sand market has also been witnessing the increasing focus toward R&D activities. However, increasing use of recycled silica sand could pose a challenge to the growth of this market.   TechNavio's report, Global Industrial Silica Sand Market 2012-2016, has been prepared based on an in-depth market analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers Global Industrial Silica Sand market landscape and its growth...
Table of Content

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology
Market Research Process
Research Design
Research Methodology

5. Scope of the Report
Market Overview
Key Offerings

6. Market Landscape
6.1 Market Size and Forecast
6.2 End-user Segmentation
6.3 Five Forces Analysis

7. Geographical Segmentation

8. Vendor Landscape

9. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis
15.1 Quarzwerke GmbH
Business Overview
Key Information
SWOT Analysis
15.2 U.S. Silica Holdings Inc.
Business Overview
Key Information
SWOT Analysis
15.3 Fairmount Minerals Ltd.
Business Overview
Key Information
SWOT Analysis
15.4 Sibelco Group
Business Overview
Key Information
SWOT Analysis

16. Other Reports in this Series

Exhibit 1: Market Research Methodology
Exhibit 2: Global Industrial Silica Sand Market 2012-2016 (million metric tons)
Exhibit 3: Global Industrial Silica Sand Market by End-user Segmentation 2012

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Base Oils-Lubes Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Base oils-lubes market is growing due to the increasing need for more sophisticated lubricants in the automotive industry. With the advancement in lubrication technology, base oils and lubricants market is expected to witness a rise in demand in the near future. Base oil quality and supply vary depending on the region and hence it is an important product in global trading. Growing economies are making huge investments in base oils-lubes market for developing higher grade base oils and lubricants to fulfill the growing demands from the industrial and automotive markets. ...
Endometriosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor. This disease affects over 170 million females across the globe. Endometriosis has an unclear etiology and complex symptoms. These factors contribute in difficulties for timely diagnosis and obstruct the drug discovery processes. Endometriosis is a major cause of infertility in female population. Endometriosis treatment includes pain management through hormonal therapies and surgical...
Bone and Joint Health Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Bone and joint health concerns have grown globally, due to increased cases of fractures, back and neck pains, bone ailments and trauma. Bone and joints health supplements industry has been offering diverse value-added functional ingredients, belonging to different health segments. Some of the commonly used bone health ingredients include calcium, soy isoflavones, prebiotic fiber and vitamins. Ingredients used in making these supplements are glucosamine, collagen peptide, chondroitin, methylsulfonyl methane, hyaluronic acid, boswellia serrate and omega-3 fatty acids....

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...